BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug CethrinŽ to Boston Life Sciences
December 2006: Gazette Article - Biotech firms face difficult challenges
November 2006: BioAxone Therapeutic Study Demonstrates Positive Interim Results for Spinal Cord Injury
Novembre 2006: Interview de Patrick Tremblay au Canal Argent
November 2005: Walk Again: FORBES Magazine looks at BioAxone.